Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A pulse oximeter (Ohmeda Biox 3700) and two transcutaneous systems (Radiometer TCM3) were applied simultaneously to 18 newborn infants with respiratory insufficiency. All infants had either an umbilical catheter placed in the mid thoracic aorta or a radial artery catheter. The average monitoring time was 2 hours. Arterial blood pO2, pCO2 and pH (Radiometer ABL300), arterial sO2, HbCO and metHb (Radiometer OSM3), erythrocyte 2,3 DPG concentration, and fetal hemoglobin fraction (alkali denaturation kinetic method) were measured. Using arterial sO2 and pO2 as reference, the analytical bias of pulse oximetry (-0.5 +/- 1.0%, mean +/- 1 SD) corresponded in magnitude, when converted to pO2, to that of transcutaneous - pO2 (0.6 +/- 1.4 kPa for combined O2-CO2 electrode and -0.1 +/- 2.3 kPa for single O2 electrode). Transcutaneous pCO2 showed the smallest bias (0.3 +/- 0.3 kPa). Both pulse oximetry and transcutaneous pO2 electrodes were good as trend monitors detecting rapid changes in the infants' oxygenation status. The pulse oximeter offers certain advantages in not requiring calibration or heating. The variations in the levels of fetal hemoglobin fraction (44 to 97%), pH (7.27 to 7.49), pCO2 (3.3 to 6.8 kPa) and 2,3 diphosphoglycerate concentration (1.6 to 5.9 mmol/l) between the infants studied, resulted in a variable pO2-sO2 relation (
p50
2.5 to 3.5 kPa). This presents difficulties in interpreting sO2 values in sick newborn infants, and we therefore recommend caution in using a pulse oximeter to apply strict limits for avoiding hypoxia and
hyperoxia
in this population.
...
PMID:Pulse oximetry versus transcutaneous pO2 in sick newborn infants. 245 78
In recent years clinicians caring for sick preterm infants have come to depend on pulse oximetry to avoid
hyperoxia
, which means assuming saturation values for critical levels of oxygen tension. This prediction is made difficult by the shape of the haemoglobin-oxygen dissociation curve at critical values for arterial pO2 and by the effects of changes in acid-base balance on
p50
. Combined blood gas and co-oximetry measurements can be used to determine critical limits for pulse oximetry. Fetal haemoglobin has slightly different light absorption characteristics from adult haemoglobin. To adjust for this, adult and fetal matrices are available in the OSM 3 HEMOXIMETER (Radiometer Medical A/S, Denmark) but the measurement requires an extra preliminary step to estimate fetal haemoglobin concentration. We sought to determine the importance of this extra procedure for measuring the saturation of newborn blood, and to determine whether the adult or fetal mode should be used for determining saturation for comparison with pulse oximeters. We measured the effect of the correction for fetal haemoglobin by obtaining absorbances from the co-oximeter and multiplying them by the adult and fetal matrices. We demonstrated that, at 90% saturation, failure to use the fetal correction in the presence of high levels of fetal haemoglobin result in a 4% overestimate of saturation, with resultant underestimation of the safe range for pulse oximetry. Published values for extinction coefficients for fetal and adult blood at wavelengths used by pulse oximeters are inconsistent, but it appears that fetal haemoglobin does not bias pulse oximetry readings. Determining saturation limits by co-oximetry for use with pulse oximeters in preterm infants requires the description of the haemoglobin-oxygen dissociation curve with the correction for fetal haemoglobin.
...
PMID:From oxygen content to pulse oximetry: completing the picture in the newborn. 859 8
Oxygen supply was corrected in rabbits during the hepatic ischemia/reperfusion by means of different breathing mixtures: hypoxic (14.8 % O(2)+85.2 % N(2)), hyperoxic (78 % O(2)+20.2 % N(2)+ 1.8 % CO(2)), or hypercapnic (5 % CO(2) in air). Hepatic ischemia was induced for 30 min by ligation of hepatic artery, reperfusion period lasted 120 min. Indices of blood oxygen transport (
p50
(act), pCO(2), pH, pO(2), etc.) and prooxidant-antioxidant balance (Schiff bases, conjugated dienes, catalase, retinol, alpha-tocopherol) were measured in the blood and liver. The severity of reperfusion damage was evaluated by the activities of alanine and aspartate aminotransferases (ALT, AST) in the blood. Hepatic ischemia/reperfusion resulted in higher
p50
(act) in hepatic venous and mixed venous blood in all experimental groups. The changes of
p50
(act) were most marked in the hypercapnic group and were the weakest in the hypoxic group. The rise in
p50
(act) was accompanied by higher levels of lipid peroxidation products, ALT and AST in blood and liver homogenates, and by a simultaneous fall of alpha-tocopherol and retinol concentrations, except in the hypoxic group. Catalase activity at the end of reperfusion increased under normoxia, decreased under
hyperoxia
or hypercapnia and did not change under hypoxia. The moderate hypoxia during reperfusion was accompanied by a better balance between the mechanisms of reactive oxygen species production and inactivation that may be observed by optimal changes in p50act and reduced the hepatic damage in this pathological condition.
...
PMID:Influence of different oxygen modes on the blood oxygen transport and prooxidant-antioxidant status during hepatic ischemia/reperfusion. 1453 28
Neonatal rodents are more tolerant to
hyperoxia
than adults. We determined whether maturational differences in lung NF-kappaB activation could account for the differences. After hyperoxic exposure (O2 > 95%), neonatal (<12 hours old) lung NF-kappaB binding was increased and reached a maximum between 8 and 16 hours, whereas in adults no changes were observed. Additionally, neonatal NF-kappaB/luciferase transgenic mice (incorporating 2 NF-kappaB consensus sequences driving luciferase gene expression) demonstrated enhanced in vivo NF-kappaB activation after
hyperoxia
in real time. In the lungs of neonates, there was a propensity toward NF-kappaB activation as evidenced by increased lung I-kappaB kinase protein levels, I-kappaBalpha phosphorylation, beta-transducin repeat-containing protein levels, and total I-kappaBalpha degradation. Increased lung p-JNK immunoreactive protein was observed only in the adult lung. Inhibition of pI-kappaBalpha by BAY 11-7085 resulted in decreased Bcl-2 protein levels in neonatal lung homogenates and decreased cell viability in lung primary cultures after hyperoxic exposure. Furthermore, neonatal
p50
-null mutant (
p50
(-/-)) mice showed increased lung DNA degradation and decreased survival in
hyperoxia
compared with WT mice. These data demonstrate that there are maturational differences in lung NF-kappaB activation and that enhanced NF-kappaB may serve to protect the neonatal lung from acute hyperoxic injury via inhibition of apoptosis.
...
PMID:Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. 1534 85